x |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
o |
TRANSITION
REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF
1934
|
Delaware
|
33-0565710
|
(State
or other jurisdiction of
|
(IRS
Employer Identification No.)
|
incorporation
or organization)
|
Class
|
Shares
Outstanding
|
Date
|
Common,
$.001 par value
|
26,548,292
|
July
25, 2007
|
Part
I. Financial Information
|
||
Item
1.
|
Consolidated
Financial Statements
|
|
Unaudited
Consolidated Balance Sheet - as of June 30, 2007 and March 31,
2007
|
3
|
|
Unaudited
Consolidated Statements of Operations for the three months ended
June 30,
2007 and 2006 and for the period from inception, August 19, 1999,
to June
30, 2007
|
4
|
|
Unaudited
Consolidated Statement of Changes in Shareholders' Deficit for the
period
from inception, August 19, 1999, to June 30, 2007
|
5
|
|
Unaudited
Consolidated Statements of Cash Flows for the three months ended
June 30,
2007 and 2006 and for the period from inception, August 19, 1999,
to June
30, 2007
|
6
|
|
Notes
to the Unaudited Consolidated Financial Statements
|
7
|
|
Item 2. | Management's Discussion and Analysis or Plan of Operation |
8
|
Item 3. | Controls and Procedures |
11
|
Part
II. Other Information
|
||
Item
1.
|
Legal
Proceedings
|
12
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
12
|
Item
3.
|
Defaults
Upon Senior Securities
|
12
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
12
|
Item
5.
|
Other
Information
|
12
|
Item
6.
|
Exhibits
|
12
|
June
30, 2007
|
March
31, 2007
|
||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and Cash equivalents
|
$
|
397
|
$
|
1,781
|
|||
Due
from affiliate
|
14,123
|
-
|
|||||
Note
receivable, net of impairment allowance of $0 and $10,710
|
-
|
400,000
|
|||||
Deferred
financing costs
|
14,427
|
11,438
|
|||||
Total
current assets
|
28,947
|
413,219
|
|||||
Deferred
financing costs, net of amortization of $4,752 and $2,806
|
70,821
|
75,756
|
|||||
Total
assets
|
$
|
99,768
|
$
|
488,975
|
|||
LIABILITIES
AND SHAREHOLDERS' DEFICIT
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable and accrued liabilities
|
$
|
145,395
|
$
|
154,410
|
|||
Derivative
liabilities
|
1,870,209
|
1,396,245
|
|||||
Notes
payable - shareholder
|
8,500
|
35,000
|
|||||
Due
to affiliate
|
-
|
13,078
|
|||||
Total
current liabilities
|
2,024,104
|
1,598,733
|
|||||
Callable
secured convertible notes payable net of unamortized discount of
$588,720
and $592,806
|
11,280
|
7,194
|
|||||
Total
liabilities
|
2,035,384
|
1,605,927
|
|||||
Shareholders'
deficit:
|
|||||||
Preferred
shares - $0.001 par value; 1,000,000 authorized, no shares issued
or
outstanding
|
-
|
-
|
|||||
Common
shares - $0.001 par value; 50,000,000 authorized; 26,548,292 shares
issued
and outstanding
|
26,548
|
26,548
|
|||||
Additional
paid - in capital
|
7,080,898
|
7,080,898
|
|||||
Deficit
accumulated during the development stage
|
(9,043,062
|
)
|
(8,224,398
|
)
|
|||
Total
shareholders' deficit
|
(1,935,616
|
)
|
(1,116,952
|
)
|
|||
Total
liabilities and shareholders' deficit
|
$
|
99,768
|
$
|
488,975
|
Three
Months Ended
|
Inception
to
|
|||||||||
June
30,
|
June
30,
|
June
30,
|
||||||||
2007
|
2006
|
2007
|
||||||||
Expenses
|
||||||||||
General
and administrative
|
$
|
325,629
|
-
|
$
|
1,247,863
|
|||||
Impairment
of note receivable
|
-
|
-
|
10,701
|
|||||||
Total
expenses
|
325,629
|
-
|
1,258,564
|
|||||||
Loss
from operations
|
(325,629
|
)
|
-
|
(1,258,564
|
)
|
|||||
Other
income (expense)
|
||||||||||
Interest
income
|
-
|
-
|
10,701
|
|||||||
Interest
expense
|
(19,071
|
)
|
-
|
(45,268
|
)
|
|||||
Change
in fair value of derivatives
|
(473,964
|
)
|
-
|
(1,270,209
|
)
|
|||||
Total
other income/(expense)
|
(493,035
|
)
|
-
|
(1,304,776
|
)
|
|||||
Loss
from continuing operations
|
(818,664
|
)
|
-
|
(2,563,340
|
)
|
|||||
Discontinued
operations
|
||||||||||
Loss
from operations of subsidiary
|
-
|
(433,538
|
)
|
(6,778,804
|
)
|
|||||
Gain
on disposal of subsidiary
|
-
|
-
|
299,082
|
|||||||
Loss
from discontinued operations
|
-
|
(433,538
|
)
|
(6,479,722
|
)
|
|||||
Net
loss
|
$
|
(818,664
|
)
|
$
|
(433,538
|
)
|
$
|
(9,043,062
|
)
|
|
Weighted
Average Shares Outstanding - basic and diluted
|
26,548,292
|
24,612,455
|
||||||||
Basic
and diluted loss per share
|
||||||||||
Continuing
Operations
|
$
|
(0.03
|
)
|
$
|
-
|
|||||
Discontinued
Operations
|
$
|
-
|
$
|
(0.02
|
)
|
|||||
Net
Loss
|
$
|
(0.03
|
)
|
$
|
(0.02
|
)
|
Additional
|
During the
|
Losses
|
||||||||||||||
Common Stock
|
Paid-In
|
Development
|
Accumulated
|
|||||||||||||
Shares
|
Amount
|
Capital
|
Stage
|
Total
|
||||||||||||
Balance
at Inception, August 19,1999
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||||
Issuance
of common stock
|
20,000
|
20
|
-
|
-
|
20
|
|||||||||||
Net
loss
|
-
|
-
|
-
|
(84,021
|
)
|
(84,021
|
)
|
|||||||||
Balance
at December 31, 1999
|
20,000
|
20
|
-
|
(84,021
|
)
|
(84,001
|
)
|
|||||||||
Net
loss
|
-
|
-
|
-
|
(230,879
|
)
|
(230,879
|
)
|
|||||||||
Balance
at December 31, 2000
|
20,000
|
20
|
-
|
(314,900
|
)
|
(314,880
|
)
|
|||||||||
Net
loss
|
-
|
-
|
-
|
(494,816
|
)
|
(494,816
|
)
|
|||||||||
Balance
at December 31, 2001
|
20,000
|
20
|
-
|
(809,716
|
)
|
(809,696
|
)
|
|||||||||
Net
loss
|
-
|
-
|
-
|
(384,590
|
)
|
(384,590
|
)
|
|||||||||
Balance
at December 31, 2002
|
20,000
|
20
|
-
|
(1,194,306
|
)
|
(1,194,286
|
)
|
|||||||||
Reclassification
of debt to equity
|
43,000
|
43
|
1,581,940
|
-
|
1,581,983
|
|||||||||||
Net
loss
|
-
|
-
|
-
|
(736,364
|
)
|
(736,364
|
)
|
|||||||||
Balance
at December 31, 2003
|
63,000
|
63
|
1,581,940
|
(1,930,670
|
)
|
(348,667
|
)
|
|||||||||
Effect
of issuance of common stock and recapitalization in a reverse acquisition
transaction
|
25,943,925
|
25,944
|
(25,944
|
)
|
-
|
-
|
||||||||||
Net
loss
|
-
|
-
|
-
|
(205,994
|
)
|
(205,994
|
)
|
|||||||||
Balance
at March 31, 2004
|
26,006,925
|
26,007
|
1,555,996
|
(2,136,664
|
)
|
(554,661
|
)
|
|||||||||
Proceeds
from issuance of common stock
|
603,856
|
604
|
301,324
|
-
|
301,928
|
|||||||||||
Cancellation
of shares
|
(3,502,925
|
)
|
(3,503
|
)
|
3,503
|
-
|
-
|
|||||||||
Net
loss
|
-
|
-
|
(1,592,469
|
)
|
(1,592,469
|
)
|
||||||||||
Balance
at March 31, 2005
|
23,107,856
|
23,108
|
1,860,823
|
(3,729,133
|
)
|
(1,845,202
|
)
|
|||||||||
Proceeds
from issuance of common stock
|
276,400
|
276
|
276,124
|
-
|
276,400
|
|||||||||||
Stock
issued for accounts payable
|
50,000
|
50
|
49,950
|
-
|
50,000
|
|||||||||||
Stock
issued for conversion of debt
|
1,050,000
|
1,050
|
1,048,950
|
-
|
1,050,000
|
|||||||||||
Net
loss
|
-
|
-
|
-
|
(1,376,529
|
)
|
(1,376,529
|
)
|
|||||||||
Balance
at March 31, 2006
|
24,484,256
|
24,484
|
3,235,847
|
(5,105,662
|
)
|
(1,845,331
|
)
|
|||||||||
Proceeds
from issuance of common stock
|
24,694
|
25
|
24,670
|
-
|
24,695
|
|||||||||||
Stock
issued for services
|
1,102,000
|
1,102
|
1,306,500
|
-
|
1,307,602
|
|||||||||||
Stock
issued for debt
|
817,342
|
817
|
1,838,204
|
-
|
1,839,021
|
|||||||||||
Stock
issued for investment
|
3,000,000
|
3,000
|
4,017,000
|
-
|
4,020,000
|
|||||||||||
Stock
rescinded relating to investment
|
(2,880,000
|
)
|
(2,880
|
)
|
(3,856,323
|
)
|
-
|
(3,859,203
|
)
|
|||||||
Expenses
paid by shareholder
|
-
|
-
|
515,000
|
-
|
515,000
|
|||||||||||
Net
loss
|
-
|
-
|
-
|
(3,118,736
|
)
|
(3,118,736
|
)
|
|||||||||
Balance
at March 31, 2007
|
26,548,292
|
26,548
|
7,080,898
|
(8,224,398
|
)
|
(1,116,952
|
)
|
|||||||||
Net
loss
|
-
|
-
|
-
|
(818,664
|
)
|
(818,664
|
)
|
|||||||||
Balance
at June 30, 2007
|
26,548,292
|
$
|
26,548
|
$
|
7,080,898
|
$
|
(9,043,062
|
)
|
$
|
(1,935,616
|
)
|
Three
Months Ended
|
Inception
to
|
|||||||||
June
30,
|
June
30,
|
June
30,
|
||||||||
2007
|
2006
|
2007
|
||||||||
Cash
Flows from Operating Activities:
|
||||||||||
Net
loss
|
$
|
(818,664
|
)
|
$
|
(433,538
|
)
|
$
|
(9,043,062
|
)
|
|
Loss
on discontinued operations
|
-
|
433,538
|
6,479,722
|
|||||||
Loss
from continuing operations
|
(818,664
|
)
|
-
|
(2,563,340
|
)
|
|||||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||
Impairment
of loan receivable
|
-
|
-
|
10,701
|
|||||||
Stock
issued for services
|
-
|
-
|
692,650
|
|||||||
Amortization
of deferred financing costs
|
1,946
|
-
|
4,752
|
|||||||
Accretion
of discount on convertible notes
|
4,086
|
-
|
11,280
|
|||||||
Change
in fair value of derivatives
|
473,964
|
-
|
1,270,209
|
|||||||
Changes
in
|
||||||||||
Accounts
payable and accrued liabilities
|
(9,015
|
)
|
-
|
145,393
|
||||||
Due
to affiliate
|
(27,201
|
)
|
-
|
(14,123
|
)
|
|||||
Interest
receivable
|
-
|
-
|
(10,701
|
)
|
||||||
Net
cash used in operating activities
|
(374,884
|
)
|
-
|
(453,179
|
)
|
|||||
Cash
Flows from Investing Activities
|
||||||||||
Investment
in note receivable
|
-
|
-
|
(400,000
|
)
|
||||||
Proceeds
from note receivable
|
400,000
|
-
|
400,000
|
|||||||
Net
cash provided by investing activities
|
400,000
|
-
|
-
|
|||||||
Cash
Flows from Financing Activities
|
||||||||||
Proceeds
from issuance of common stock
|
-
|
-
|
24,695
|
|||||||
Proceeds
from notes payable - shareholder
|
8,500
|
-
|
43,500
|
|||||||
Proceeds
from convertible notes payable
|
-
|
-
|
600,000
|
|||||||
Payments
on notes payable - shareholder
|
(35,000
|
)
|
-
|
(35,000
|
)
|
|||||
Debt
issuance costs
|
-
|
-
|
(90,000
|
)
|
||||||
Net
cash provided by financing activities
|
(26,500
|
)
|
-
|
543,195
|
||||||
Discontinued
operations
|
||||||||||
Discontinued
operating activities
|
-
|
(139,230
|
)
|
(4,506,211
|
)
|
|||||
Discontinued
investing activities
|
-
|
(373
|
)
|
(187,748
|
)
|
|||||
Discontinued
financing activities
|
-
|
84,695
|
4,604,340
|
|||||||
Net
cash provided by (used in) discontinued operations
|
-
|
(54,908
|
)
|
(89,619
|
)
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
(1,384
|
)
|
(54,908
|
)
|
397
|
|||||
Cash
and cash equivalents
|
||||||||||
Beginning
of period - continuing operations
|
1,781
|
-
|
-
|
|||||||
Beginning
of period - discontinued operations
|
-
|
62,383
|
-
|
|||||||
End
of period - continuing operations
|
$
|
397
|
$
|
-
|
$
|
397
|
||||
End
of period - discontinued operations
|
$
|
-
|
$
|
7,475
|
$
|
-
|
Description
|
June
30, 2007
|
March
31, 2007
|
|||||
Derivative
liability - single compound embedded derivatives Within the convertible
notes
|
$
|
26,319
|
$
|
27,210
|
|||
Derivative
liability - warrants
|
1,843,890
|
1,369,035
|
|||||
Total
|
$
|
1,870,209
|
$
|
1,396,245
|
Description
|
June
30, 2007
|
March
31, 2007
|
|||||
Risk-free
interest rate
|
4.89
|
%
|
4.54
|
%
|
|||
Default
status
|
10.00
|
%
|
10.00
|
%
|
|||
Alternative
financing available and exercised
|
1.00
|
%
|
1.00
|
%
|
|||
Trading
volume, gross monthly rate increase
|
1.00
|
%
|
1.00
|
%
|
|||
Annual
growth rate of stock price
|
22.05
|
%
|
21.76
|
%
|
|||
Future
projected volatility
|
125.85
|
%
|
100.00
|
%
|
June
30, 2007
|
March
31, 2007
|
||||||
Risk-free
interest rate
|
4.96
|
%
|
4.58
|
%
|
|||
Expected
warrant life
|
6.42
years
|
6.67
years
|
|||||
Expected
volatility
|
141.90
|
%
|
119.82
|
%
|
|||
none
|
none
|
||||||
Exercise
pricing reset probability
|
10
|
%
|
-
|
31.1 |
Certification
of the Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
31.2 |
Certification
of the Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
32.1 |
Certification
of the Principal Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
32.2 |
Certification
of the Principal Financial Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|